Position in BIIB
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$563,700
+$87,042 QoQ
Shares Held
2,609
+0.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#557
of 1,031 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIIB Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EAGLE GLOBAL ADVISORS LLC holds $90,990,326 across 10 Drug Manufacturers - General names. BIIB ranks #7 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
89,170 | $22,646,504 | |
| 2 | LLY |
ELI LILLY & Co
|
17,945 | $21,523,773 | |
| 3 | ABBV |
AbbVie Inc.
|
79,227 | $19,936,682 | |
| 4 | MRK |
Merck & Co., Inc.
|
138,101 | $17,745,978 | |
| 5 | AZN |
Astrazeneca PLC
|
37,609 | $7,131,418 | |
| 6 | AMGN |
Amgen Inc
|
1,640 | $593,876 | |
| 7 | BIIB |
Biogen Inc.
This page
|
2,609 | $563,700 | |
| 8 | PFE |
Pfizer Inc
|
13,800 | $332,304 |
All Filings in BIIB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $563,700 | 2,609 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $476,658 | 2,600 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $457,574 | 2,600 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $367,710 | 2,625 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $329,673 | 2,625 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $359,205 | 2,625 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $401,415 | 2,625 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $508,830 | 2,625 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $608,527 | 2,625 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $566,028 | 2,625 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $679,271 | 2,625 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $674,651 | 2,625 | Shares | Sole | 2023-10-30 | |
| 2023-06-30 | $747,731 | 2,625 | Shares | Sole | 2023-07-21 | |
| 2023-03-31 | $729,828 | 2,625 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $726,915 | 2,625 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $700,875 | 2,625 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $535,342 | 2,625 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $552,825 | 2,625 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $629,790 | 2,625 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $742,848 | 2,625 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $908,958 | 2,625 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $734,343 | 2,625 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $642,757 | 2,625 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $744,660 | 2,625 | Shares | Sole | 2020-10-22 | |
| 2020-06-30 | $702,318 | 2,625 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $830,497 | 2,625 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||